Dr. Bruce Quinn is a professional strategy consultant helping innovative companies achieve their goals under U.S. federal health policies. His consulting practice, with offices in Los Angeles and San Francisco, works with leading genomic, medical technology, and biopharma companies. Originally trained as a neuropathologist, earlier in his career he held tenure-track faculty positions at NYU Medical School and the Northwestern University School of Medicine. As a physician executive, he has held positions with Accenture’s healthcare strategies practice, the Medicare program, and with health policy groups in two law and lobbying firms.
Recent publications have included articles on defining clinical utility for diagnostic tests and a review of the emerging digital genomics industry. In addition, his blog, Discoveries in Health Policy, covers innovative health care policy developments and receives over 100,000 hits per year.
Dr. Quinn received his MD/PhD from Stanford University. Additionally, he was a postdoctoral fellow in neuroscience at MIT and completed his residency in pathology and neuropathology at UCLA. He also holds an MBA from the Kellogg School of Management at Northwestern University.